DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Baxter International, Inc. 

One Baxter Parkway

Deerfield  Illinois  60015  U.S.A.
Phone: 847-948-2000 Fax: 847-948-3642


SEARCH JOBS




Baxter International, Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

Business Overview:

BioScience
Baxter is a leading manufacturer of plasma-based and recombinant proteins used to treat hemophilia. Other biopharmaceutical products include plasma-based therapies to treat immune disorders, alpha 1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Baxter also is a leading manufacturer of manual and automated blood and blood-component separation and collection systems.

Medication Delivery
Baxter is a leading manufacturer of intravenous (IV) solutions and administration sets, premixed drugs and drug reconstitution systems, pre-filled vials and syringes for injectable drugs, electronic infusion pumps, and other products used to deliver fluids and drugs to patients. The company also provides IV nutrition solutions, containers and compounding systems and services; general anesthetic agents and critical care drugs; contract manufacturing services, and drug packaging and formulation technologies.

Renal
Baxter is a leading manufacturer of products for peritoneal dialysis (PD), a home therapy for people with end-stage renal disease, or irreversible kidney failure. These products include a range of PD solutions and related supplies to help patients safely perform solution exchanges, as well as automated PD cyclers that perform solution exchanges for patients overnight while they sleep. Baxter also distributes instruments and disposables, including dialyzers, for hemodialysis, generally conducted in a hospital or clinic.

Because of our commitment to research and development, Baxter’s history is rich with medical firsts, from the first commercially manufactured intravenous (IV) solutions to the first portable kidney dialysis machine, plus many more. Baxter continually pursues breakthrough technologies through research facilities around the world, and our investments reflect that commitment.

 Key Statistics


Email:
Ownership: Public

Web Site: Baxter International
Employees:
Symbol: BAX
 





Collaborations

Progenitor Cell Therapy 





 Company News
CTI BioPharma, Baxter International (BAX)'s Blood Cancer Drug Meets Main Goal in Late-Stage Trial 3/9/2015 6:32:02 AM
Baxter International (BAX) Snaps Up German Biopharma for $225 Million 3/4/2015 7:41:50 AM
Baxter International (BAX) Starts Hiring in Anticipation of Planned Drug Spinout Baxalta 3/2/2015 6:26:13 AM
Baxter International, Inc. (BAX) Selects Bannockburn, Ill., Facility As Location For Baxalta Global Headquarters 2/23/2015 7:15:27 AM
Baxter International, Inc. (BAX) To Present At Barclay’s Global Healthcare Conference 2/20/2015 11:12:49 AM
Baxter International, Inc. (BAX) Declares Quarterly Dividend 2/17/2015 12:32:00 PM
Baxter International, Inc. (BAX) Provides Progress Update On Gene Therapy Program, Including Phase 1/2 Clinical Trial Of BAX 335, Investigational Gene Therapy Treatment For Hemophilia B 2/13/2015 10:22:40 AM
Baxter International, Inc. (BAX) To Present At Cowen and Company’s 35th Annual Health Care Conference 2/11/2015 11:55:17 AM
Baxter International, Inc. (BAX) Presents Additional Data From Pivotal Study Of BAX 855, Extended Half-Life Investigational Recombinant FVIII Based On ADVATE For Hemophilia A 2/11/2015 10:49:42 AM
Baxter International, Inc. (BAX)’s Fourth Quarter Financial Results Exceed Expectations 1/29/2015 11:13:14 AM
12345678910...